Atossa Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . Atossa Genetics
ATOS Stock  USD 0.69  0.01  1.47%   
Atossa Genetics' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Atossa Genetics' valuation are provided below:
Market Capitalization
88.7 M
Earnings Share
(0.23)
There are over one hundred nineteen available fundamental signals for Atossa Genetics, which can be analyzed over time and compared to other ratios. All traders should validate Atossa Genetics' prevailing fundamentals against the performance from 2010 to 2025 and make sure the trends continue to evolve in the right direction. Market Cap is likely to gain to about 112.3 M in 2025. Enterprise Value is likely to gain to about 57.6 M in 2025

Atossa Genetics Total Revenue

0.0

Check Atossa Genetics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Atossa Genetics' main balance sheet or income statement drivers, such as Other Operating Expenses of 14.6 M, Research Development of 14.8 M or Total Operating Expenses of 14.5 M, as well as many indicators such as Price To Sales Ratio of 7.6 K, Dividend Yield of 0.0 or PTB Ratio of 1.58. Atossa financial statements analysis is a perfect complement when working with Atossa Genetics Valuation or Volatility modules.
  
Build AI portfolio with Atossa Stock
Check out the analysis of Atossa Genetics Correlation against competitors.
For more information on how to buy Atossa Stock please use our How to Invest in Atossa Genetics guide.

Atossa Genetics Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets38.4 M76.4 M37.3 M
Slightly volatile
Short and Long Term Debt Total15.4 K16.2 K95.7 K
Slightly volatile
Other Current Liabilities2.7 M4.3 M2.6 M
Slightly volatile
Total Current Liabilities3.5 M5 M3.4 M
Slightly volatile
Total Stockholder Equity75.1 M71.5 M36.5 M
Slightly volatile
Cash74.6 M71.1 M36 M
Slightly volatile
Non Current Assets Total1.9 M2 M1.8 M
Very volatile
Non Currrent Assets Other2.1 M2 M500.9 K
Slightly volatile
Cash And Short Term Investments74.6 M71.1 M36 M
Slightly volatile
Common Stock Shares Outstanding132.2 M125.9 M40.8 M
Slightly volatile
Liabilities And Stockholders Equity38.4 M76.4 M37.3 M
Slightly volatile
Other Stockholder Equity272.8 M259.8 M117.9 M
Slightly volatile
Total Liabilities3.5 M5 M3.4 M
Slightly volatile
Total Current Assets78.2 M74.5 M38.1 M
Slightly volatile
Short Term Debt15.4 K16.2 K87.9 K
Slightly volatile
Common Stock24.7 M23.5 M8 M
Slightly volatile
Common Stock Total Equity27.5 M26.2 M8.7 M
Slightly volatile
Property Plant And Equipment Net17.1 K18 K84.6 K
Slightly volatile
Accounts Payable828.4 K679 K714.7 K
Slightly volatile
Other Current Assets3.5 M3.4 M1.3 M
Slightly volatile
Property Plant And Equipment Gross30.8 K32.4 K88.2 K
Slightly volatile
Intangible Assets11.4 K12 K856.2 K
Slightly volatile
Property Plant Equipment17.1 K18 K81.5 K
Slightly volatile
Net Tangible Assets142.4 M135.7 M46.7 M
Slightly volatile
Capital Surpluse303.5 M289.1 M123.6 M
Slightly volatile
Current Deferred Revenue985.6 K1.2 M813.1 K
Slightly volatile
Other Liabilities1.6 K1.8 K2 K
Slightly volatile
Net Invested Capital65.3 M71.5 M36.8 M
Slightly volatile
Net Working Capital63.6 M69.5 M35.8 M
Slightly volatile
Capital Stock16.2 M23.5 M8 M
Slightly volatile

Atossa Genetics Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Other Operating Expenses14.6 M27.6 M14.1 M
Slightly volatile
Research Development14.8 M14.1 M6.1 M
Slightly volatile
Total Operating Expenses14.5 M27.6 M14 M
Slightly volatile
Depreciation And Amortization16.1 K17 K132.5 K
Slightly volatile
Selling General Administrative9.1 M13.5 M8.3 M
Slightly volatile
Selling And Marketing Expenses16.9 M16.1 M9.4 M
Slightly volatile
Cost Of Revenue16.1 K17 K118.2 K
Slightly volatile
Non Recurring394.8 K415.5 K1.1 M
Slightly volatile
Interest Income4.3 M4 M911.4 K
Slightly volatile
Preferred Stock And Other Adjustments2.1 M2.3 M2.5 M
Slightly volatile
Reconciled Depreciation33.1 K17 K79.2 K
Slightly volatile

Atossa Genetics Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation2.8 M2.3 M2.6 M
Slightly volatile
Begin Period Cash Flow93 M88.6 M32.8 M
Slightly volatile
End Period Cash Flow36.9 M71.2 M33.7 M
Slightly volatile
Depreciation16.1 K17 K133.4 K
Slightly volatile
Change To Netincome8.2 M7.8 M3.7 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio7.6 K6 K7.4 K
Slightly volatile
PTB Ratio1.581.662490.0919
Slightly volatile
Days Sales Outstanding190238205
Very volatile
Book Value Per Share0.540.567922.1262
Slightly volatile
Average Payables1.6 M1.5 M760.1 K
Slightly volatile
Stock Based Compensation To Revenue452430336
Slightly volatile
Capex To Depreciation1.661.11762.0389
Slightly volatile
PB Ratio1.581.662490.0919
Slightly volatile
EV To Sales7 K3.5 K6 K
Slightly volatile
Inventory Turnover0.01690.01781.7084
Slightly volatile
Days Of Inventory On Hand32.1 K21.2 K26.3 K
Slightly volatile
Payables Turnover0.02380.0253.6334
Slightly volatile
Sales General And Administrative To Revenue4.8 K4.5 K3.7 K
Slightly volatile
Average Inventory503.6 K716.5 K585.4 K
Slightly volatile
Research And Ddevelopement To Revenue1.3 K1.2 K910
Slightly volatile
Capex To Revenue89.885.5264.3058
Slightly volatile
Cash Per Share0.540.564816.0178
Slightly volatile
Days Payables Outstanding12.1 K14.6 K14 K
Slightly volatile
Income Quality0.790.82460.7218
Pretty Stable
Intangibles To Total Assets3.0E-44.0E-40.1054
Slightly volatile
Net Debt To EBITDA2.932.7891.7514
Slightly volatile
Current Ratio15.7414.99039.852
Slightly volatile
Tangible Book Value Per Share0.540.567912.9485
Slightly volatile
Receivables Turnover2.191.591.9895
Pretty Stable
Shareholders Equity Per Share0.540.567922.1262
Slightly volatile
Debt To Equity7.0E-48.0E-40.0527
Slightly volatile
Capex Per Share1.0E-42.0E-41.0336
Slightly volatile
Graham Net Net0.50.52539.9977
Slightly volatile
Average Receivables594.3 K566 K375.3 K
Slightly volatile
Revenue Per Share0.01220.01281.1525
Slightly volatile
Interest Debt Per Share0.00170.00181.3986
Slightly volatile
Debt To Assets5.0E-45.0E-40.0262
Slightly volatile
Operating Cycle25.7 K21.2 K26 K
Slightly volatile
Price Book Value Ratio1.581.662490.0919
Slightly volatile
Days Of Payables Outstanding12.1 K14.6 K14 K
Slightly volatile
Ebt Per Ebit1.10.92341.0033
Very volatile
Company Equity Multiplier1.431.06951.386
Slightly volatile
Total Debt To Capitalization7.0E-48.0E-40.0355
Slightly volatile
Debt Equity Ratio7.0E-48.0E-40.0527
Slightly volatile
Quick Ratio15.7414.99039.6048
Slightly volatile
Net Income Per E B T0.91.111.1918
Pretty Stable
Cash Ratio15.0314.31139.2415
Slightly volatile
Days Of Inventory Outstanding32.1 K21.2 K26.3 K
Slightly volatile
Days Of Sales Outstanding190238205
Very volatile
Free Cash Flow Operating Cash Flow Ratio1.111.00091.022
Pretty Stable
Price To Book Ratio1.581.662490.0919
Slightly volatile
Fixed Asset Turnover0.01120.01180.5321
Slightly volatile
Debt Ratio5.0E-45.0E-40.0262
Slightly volatile
Price Sales Ratio7.6 K6 K7.4 K
Slightly volatile
Asset Turnover3.0E-43.0E-40.0108
Slightly volatile
Price Fair Value1.581.662490.0919
Slightly volatile

Atossa Genetics Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap112.3 M106.9 M49.6 M
Slightly volatile

Atossa Fundamental Market Drivers

Atossa Upcoming Events

27th of March 2024
Upcoming Quarterly Report
View
20th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
27th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Atossa Genetics Financial Statements

Atossa Genetics shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Atossa Genetics investors may analyze each financial statement separately, they are all interrelated. The changes in Atossa Genetics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Atossa Genetics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue1.2 M985.6 K
Cost Of Revenue17 K16.1 K
Stock Based Compensation To Revenue 430.09  451.59 
Sales General And Administrative To Revenue4.5 K4.8 K
Research And Ddevelopement To Revenue1.2 K1.3 K
Capex To Revenue 85.52  89.80 
Revenue Per Share 0.01  0.01 
Ebit Per Revenue-8.3 K-7.9 K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Atossa Stock Analysis

When running Atossa Genetics' price analysis, check to measure Atossa Genetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atossa Genetics is operating at the current time. Most of Atossa Genetics' value examination focuses on studying past and present price action to predict the probability of Atossa Genetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Atossa Genetics' price. Additionally, you may evaluate how the addition of Atossa Genetics to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2025 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY